Vancomycin induced DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) in a patient with tricuspid endocarditis.
Lynsey Jane HewitsonPublished in: BMJ case reports (2019)
A 57-year-old man presented for an elective pacemaker upgrade, complicated by the discovery of device infection. He had a background of complex congenital heart disease, including replacement of heart valves, and was treated for presumed infective endocarditis that was later confirmed by echocardiography. Antibiotic treatment, with intravenous vancomycin, was given as per the tissue sample sensitivities. On day 24 of treatment he deteriorated clinically, with the evolution of recurrent fever, epigastric pain, diarrhoea, widespread pruritic rash, lymphadenopathy and severe hypoxia over the subsequent 7-10 days. Blood tests revealed development of a marked eosinophilia, transaminitis and rising inflammatory markers. Further radiological imaging was non-diagnostic. On the basis of these clinical and biochemical features a diagnosis of drug reaction with eosinophilia and systemic symptoms syndrome was made. This led to the cessation of vancomycin, the offending agent and the referral for specialist immunology advice. He was subsequently treated with oral prednisolone and made a full recovery.
Keyphrases
- congenital heart disease
- drug induced
- case report
- methicillin resistant staphylococcus aureus
- primary care
- chronic pain
- heart failure
- left ventricular
- palliative care
- computed tomography
- small molecule
- mitral valve
- single cell
- patients undergoing
- pulmonary embolism
- neuropathic pain
- diabetic rats
- physical activity
- spinal cord
- oxidative stress
- staphylococcus aureus
- sleep quality
- replacement therapy
- newly diagnosed
- transcatheter aortic valve replacement
- electronic health record
- electron transfer